RavenQuest Announces Dr. Simerjeet Kaur Will Lead Scientific Research & Development

VANCOUVER, British Columbia, March 14, 2018 (GLOBE NEWSWIRE) — RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE:RQB) is pleased to announce it has appointed Dr. Simerjeet Kaur, PhD, to lead Scientific Research & Development.

Dr. Kaur will lead the Company’s R&D and scientific training efforts, specifically relating to the development of new high yielding, stress resistant Cannabis varieties for medicinal as well as recreational purposes.

Dr. Kaur is a leader in her field.  RavenQuest is thrilled to bring an accomplished and highly respected plant breeder and geneticist onboard.  In assembling our senior team members, our focus has been upon attracting thought leaders with proven results in their respective fields.  The addition of Dr. Kaur is yet another example of this.  The addition of Dr. Kaur, combined with our McGill University research partnership, positions RavenQuest to lead the cannabis industry with stable, high yielding cannabis expression based in science.

George Robinson, CEO of RavenQuest

As our industry matures, it’s important to deliver a consistent, repeatable experience for our end users while maximizing plant yields that keep margins healthy for shareholders.  To that end, Dr. Kaur’s expertise is instrumental to RavenQuest as we continue to build a very unique cannabis company.

Dr. Kaur is an expert in plant breeding, genetics, plant physiology and biochemistry. She obtained her Doctor of Philosophy in plant breeding and genetics from McGill University, and Master’s Degree in plant physiology and biochemistry from Punjab Agricultural University. During her PhD, she was a visiting scholar at Washington State University (USA) to work with experts in the field of molecular breeding and varietal development.

Her research led to significant contributions in varietal development, novel gene identification and gene function prediction. Through association mapping, she discovered novel genes that can be used as markers for breeding programmes to improve the ability of plants to cope with biotic and abiotic stress resistance.  Dr. Kaur has published in several peer reviewed journals on crop genetics, breeding and physiology. Her breeding program led to the development of a high yielding, stable rice variety that is currently being used in commercial rice production. She also has delivered lectures on genomics, molecular biology and plant breeding.

About RavenQuest BioMed Inc.

RavenQuest BioMed Inc. is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services and consulting, and specialized research and development.

Original Press Release

Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter